A Case of Severe Multisystem Inflammatory Syndrome in Children (MIS-C) Treated with Multiple Biologics
The COVID-19 virus has impacted global health on a wide scale, affecting humans of all ages and ethnicities. While most have mild upper respiratory viral symptoms, some have died due to severe pneumonia, acute respiratory distress syndrome (ARDS), or coagulopathies to mention a few. It has been post...
Saved in:
Main Authors: | Beenish Zulfiqar, Hira Imran, Kathleen Collins |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Rheumatology |
Online Access: | http://dx.doi.org/10.1155/2022/6181922 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum HDL and their subfractions are impaired in multisystem inflammatory syndrome in children (MIS-C)
by: Antonietta Giannattasio, et al.
Published: (2025-01-01) -
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with 2019 Novel Coronavirus (SARS-CoV-2) Infection
by: Helen Kest, et al.
Published: (2020-01-01) -
Multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19, clinical characteristics: A multi-center observational study from Jordan
by: Marwan Shalabi, et al.
Published: (2025-06-01) -
Concomitant Cytomegalovirus Viraemia in Multisystem Inflammatory Syndrome in Adults (MIS-A) following COVID-19
by: Benjamin Valente-Acosta, et al.
Published: (2024-01-01) -
IVIG plus Glucocorticoids versus IVIG Alone in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Systematic Review and Meta-Analysis
by: Robin Rauniyar, et al.
Published: (2022-01-01)